GetTopicDetailResponse(id=a48d6284cb, topicName=DSG3-CAART, introduction=DSG3-CAART, content=null, image=null, comments=2, allHits=994, url=https://h5.medsci.cn/topic?id=6284, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=99150, tagList=[TagDto(tagId=99150, tagName=DSG3-CAART)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2063792, encodeId=ba812063e9208, content=<a href='/topic/show?id=a48d6284cb' target=_blank style='color:#2F92EE;'>#DSG3-CAART#</a>, objectTitle=T細胞療法DSG3-CAART獲得FDA快速通道認證：用于治療尋常型粘膜天皰瘡, objectType=article, longId=193723, objectId=bd8a193e2301, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd8a193e2301, replyNumber=0, likeNumber=97, createdTime=2021-03-16, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd8a193e2301, moduleTitle=T細胞療法DSG3-CAART獲得FDA快速通道認證：用于治療尋常型粘膜天皰瘡, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bd8a193e2301)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2063791, encodeId=f9a42063e91de, content=<a href='/topic/show?id=a48d6284cb' target=_blank style='color:#2F92EE;'>#DSG3-CAART#</a>, objectTitle=FDA授予DSG3-CAART治療尋常型天皰瘡的孤兒藥資格, objectType=article, longId=187018, objectId=1bf918e01800, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bf918e01800, replyNumber=0, likeNumber=89, createdTime=2020-04-23, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bf918e01800, moduleTitle=FDA授予DSG3-CAART治療尋常型天皰瘡的孤兒藥資格, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1bf918e01800)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
